Hai-O Enterprise Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hai-O Enterprise Berhad with three other
drug stores in Asia:
Cosmo Bio Company Ltd
sales of 7.07 billion Japanese Yen [US$66.51 million]
Tibet Rhodiola Pharmaceutical Holding Company
(915.63 million Chinese Renmimbi [US$144.93 million]
of which 97%
was Pharmaceutical Business Trade), and
based in South Korea
(151.26 billion Korean Won [US$142.03 million]
Hai-O Enterprise Berhad reported sales of 404.24 million Malaysian Ringgits (US$103.49 million)
April of 2017.
increase of 35.8%
versus 2016, when the company's sales were 297.63 million Malaysian Ringgits.
Sales of Multi-Level Marketing saw an increase
55.8% in 2017, from
198.28 million Malaysian Ringgits to 308.95 million Malaysian Ringgits.
Not all segments of Hai-O Enterprise Berhad experienced an increase in sales in 2017:
sales of Others fell 32.8% to 4.50 million Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).
Hai-O Enterprise Berhad also experienced decreases in sales in
Wholesale (down 3.1% to 52.65 million Malaysian Ringgits)
Retail (down 0.4% to 38.15 million Malaysian Ringgits)